EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark ONCOTYPE DXX BREAST RECURRENCE SCORE was filed as Word mark on 10/22/2019 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/22/2020.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018141157 |
| Application date | October 22, 2019 |
| Publication date | January 8, 2020 |
| Entry date | May 22, 2020 |
| Expiration date | October 22, 2029 |
Trademark owner
301 Penobscot Drive
94063 Redwood City
US
94063 Redwood City
US
Trademark representatives
Rosental 4
80331 Munich
DE
goods and services
1
reagents for scientific or medical research use, namely, reagents for use in preparation of RNA samples; kits consisting primarily of enzymes for scientific and research purposes, nucleic acids, buffers, reagents and assays for use in disease testing; diagnostic kits comprised primarily of enzymes for scientific and research purposes, nucleic acids, buffers, reagents and assays for use in disease testing
5
Diagnostic kits comprised of medical diagnostic reagents and diagnostic assays for testing tissue samples for use in cancer detection, analysis and prognosis; medical reagents; medical diagnostic reagents; clinical diagnostic reagents; kits for medical purposes consisting primarily of enzymes, nucleic acids, buffers, reagents and assays for use in disease testing and classification; diagnostic kits consisting primarily of enzymes for medical purposes, nucleic acids, buffers, reagents and assays for use in disease testing and classification; medical diagnostic assays for testing of tissue samples for use in disease detection and testing for medical and prognostic purposes; medical diagnostic reagents and assays for testing tissue samples for use in disease testing and classification; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer; preparations for detecting genetic predispositions for medical purposes; biological preparations for use in the diagnosis, analysis and prognosis of cancer; diagnostic agents, preparations and substances for medical purposes; Assays for testing tissue samples for use in cancer detection, analysis and prognosis; diagnostic assays for testing tissue samples for use in cancer detection, analysis and prognosis; diagnostic kits comprised primarily of diagnostic reagents for clinical or medical laboratory use and diagnostic assays for testing tissue samples for use in cancer detection, analysis and prognosis
42
Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical research services and information in the field of cancer research and disease classification
44
Medical testing for diagnostic and prognostic purposes in the field of cancer and disease classification; providing medical information to medical professionals in the form of reports in the field of cancer and disease classification
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| September 1, 2020 | Change Representative, Published |
ID: 11018141157